NAFDAC Warns of Fake Avastin, Tecentriq
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued an urgent public warning regarding the confirmed circulation of counterfeit versions of two critical cancer medications—Avastin and Tecentriq—within the Nigerian drug supply chain, raising significant concerns about patient safety and the efficacy of cancer treatment across the country. In a public alert…